SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dauntless who wrote (1400)12/30/1997 7:58:00 PM
From: Bruce Rosen  Read Replies (2) of 7041
 
Regarding the $57.5 million "upfront" payment; I meant that it was exclusive of any royalties. My understanding is that they will get some money for various filings worldwide and some for actual approval. I believe they will get world-wide approval, as does Schering-Plough.

Since we all know that the initial payment was $10 million, I didn't anticipate the controversy my phrasing would create. No matter, time is on my side on this one. Long term, I feel extremely comfortable with Zonagen. Short term, only institutional buying will quiet those shorts who are compelled by their inner demons to be rabid. I believe it will come in time.

Daily moves, up or down, no longer concern me. The fact that the key long arguments are not effectively countered here, hearten me. Those who feel they can better evaluate the prospects of Vasomax then can Schering, amuse me.

By the way, where is the proof of the heart attack and other fantasies posted by CPA Bill? Believe his self serving drivel at your own risk!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext